Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Sep
24
2020
City of Berkeley First in the U.S. to Pass Ordinance Banning Junk Food in Checkout Lanes Keller and Heckman LLP
Sep
23
2020
Second Circuit Upholds Insider-Trading Conviction and Clarifies Scope of Requisite Fiduciary Relationship Proskauer Rose LLP
Sep
23
2020
Glyphosate Litigation Takes Criminal Turn CMBG3 Law
Sep
22
2020
China Trade Association Publishes Guidance on Classification and Labeling of Degradable Plastic Products Keller and Heckman LLP
Sep
22
2020
Vaping – The Next Wave of Lawsuits Clifford Law Offices
Sep
22
2020
FDA Proposes New Rule That Would Expand Traceability Record Keeping Requirements for Certain Foods Keller and Heckman LLP
Sep
22
2020
CMBG3 Attends MIT Event on Development of a COVID-19 Vaccine CMBG3 Law
Sep
21
2020
Germany Notifies Updated Version of its Draft Mineral Oil Ordinance to the EC Keller and Heckman LLP
Sep
19
2020
EFSA Calls for Grant Proposals on the Use of NAMs for the Hazard Assessment of Cellulose Nanofibers Bergeson & Campbell, P.C.
Sep
19
2020
At 40 Years Old, the Orange Book Gets a Fresh Look as FDA Seeks Comments on Patent Listability Squire Patton Boggs (US) LLP
Sep
18
2020
Blue Bell Fined Record $17.25 Million in Post-Conviction Criminal Penalties for Listeria Outbreak Keller and Heckman LLP
Sep
18
2020
Regulating Medical Devices Post Brexit McDermott Will & Emery
Sep
18
2020
Meat Processing: COVID Liabilities Polsinelli PC
Sep
18
2020
The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry Sheppard, Mullin, Richter & Hampton LLP
Sep
17
2020
Pennsylvania COVID-19 Restaurant Restrictions Remain Fluid Norris McLaughlin P.A.
Sep
17
2020
A NanoBCA Retrospective — A Conversation with Vincent Caprio [PODCAST] Bergeson & Campbell, P.C.
Sep
16
2020
Bioethics in a Pandemic: Vaccine Research and Clinical Trials Mintz
Sep
16
2020
White House Directs HHS to Model "Most-Favored-Nation" Price Caps for Part B and D Drugs McDermott Will & Emery
Sep
16
2020
Latest Update on FDA’s Software Pre-Cert Pilot Program Sheppard, Mullin, Richter & Hampton LLP
Sep
16
2020
Employee’s Request To Revise Drug Policy To Address CBD Use Was Not A Reasonable Accommodation Jackson Lewis P.C.
Sep
15
2020
Time to Act Against Chinese Parallel Import of Foreign Cosmetic Products Squire Patton Boggs (US) LLP
Sep
15
2020
When to Give Legal Rights to AIs? When They Can Dream Womble Bond Dickinson (US) LLP
Sep
15
2020
Trump Signs Executive Orders Aimed at Tying Domestic Drug Prices to Foreign Prices Mintz
Sep
14
2020
Trade Secret Protection & the COVID-19 Cure: Observations on Federal Policy-Making & Potential Impact on Biomedical Advances Sheppard, Mullin, Richter & Hampton LLP
Sep
14
2020
UK End of Transition – Moves to Provide Clarity for Industry Squire Patton Boggs (US) LLP
Sep
14
2020
FSIS Proposes to Expand Eligibility for Generic Label Approval and to Discontinue FSIS Evaluation of Voluntarily Submitted Labels That are Eligible for Generic Approval Keller and Heckman LLP
Sep
11
2020
China Continues Efforts to Ban and Limit Use of Plastic Products Keller and Heckman LLP
Sep
11
2020
What are the Requirements for Using Aluminum Foil as a Functional Barrier? Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins